James Cook University Hospital

Middlesbrough Ts4 3Bw

4 studies enrolling now · 26 studies all time

What they study most

Acute Coronary Syndrome, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Dissection, Aortic Valve Disease, Ascending Aorta Abnormality, Atrial Fibrillation, Back Pain, Branch Retinal Vein Occlusion, CRT-D Cardiac Resynchronization Therapy Defibrillator, Central Retinal Vein Occlusion, Chronic Pain, Conduction Disorder of the Heart

Studies at this site

• Patient Retrospective Outcomes (PRO) — Recruiting now
• RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain — Recruiting now
• Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection — Recruiting now
• Valved Graft PMCF Study — Recruiting now
• ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty Population — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) — Stopped early
• Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Running, not enrolling
• Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation — Completed
• International Guillain-Barré Syndrome Outcome Study — Completed
• AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter) — Completed
• LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices — Completed
• Rituximab Vasculitis Maintenance Study — Completed
• Spinal Cord Stimulation With Precision® System Versus Reoperation for Failed Back Surgery Syndrome — Stopped early
• Insulin Resistance Intervention After Stroke Trial — Completed
• Syncope: Pacing or Recording in the Later Years — Completed
• 10003 PRO Current Products — Completed
• Prospective, Multiconfiguration Study to Assess Functional Performance of Primary Total Knee Arthroplasty System — Completed
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) — Completed
• Study of Room Air Versus 60% Oxygen for Resuscitation of Premature Infants — Stopped early
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
• Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT) — Completed
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed